Skip to main content

The rockefeller university

Calendar of Events & Lectures

Displaying 2 of 3482 events.
Today
This Week

Thursday, November 6, 2025

Hematopoietic Stem Cells and their Niche

| CARSON FAMILY AUDITORIUM (CRC)
Seminars, Stem Cell Biology Seminars
Sean Morrison, Ph.D., founding director, Children's Medical Center Research Institute, Mary McDermott Cook Chair in Pediatric Genetics, and Kathryne and Gene Bishop Distinguished Chair in Pediatric Research, University of Texas Southwestern Medical School; investigator, Howard Hughes Medical Institute

“On the Surface…”: Transmembrane Protein Codes that Direct Synapse Formation and Function in the Brain

| 116 ROCKEFELLER RESEARCH LABORATORIES, MSKCC, 430 E. 67TH ST.
Tri-Institutional Events (at MSK & WCM), Developmental Biology Program
Timothy Mosca, Ph.D., associate professor, department of neuroscience, Thomas Jefferson University

Tri-Institutional Calendars

The close proximity among the three institutions which comprise the Tri-I has led to a culture that encourages interinstitutional interactions and shared resources, including access to lectures and seminars from internationally renowned scientists and clinicians:

Upcoming Events

Lipid Therapy: A Novel Therapeutic Strategy Utilizing Low-density Lipoproteins Against Cancer

| AUDITORIUM, ROCKEFELLER RESEARCH LABORATORIES, MSKCC, 430 E. 67TH ST.

The Tapestry of Human Prenatal Immunity

| 105 ZRC, MSKCC, 417 E. 68TH ST.

Dysregulated Nucleic Acid Sensing and Type I Interferons in Chronic Inflammation.

| 301 WRB

News

Rockefeller startup aims to change the course of treatment for severe autoimmune diseases

Nuvig, a biotech company cofounded by Jeffrey Ravetch, has launched phase two trials and raised $200 million.

Researchers develop a potential IVIG replacement for treating autoimmunity that’s significantly more potent

The discovery could greatly improve patient experience and address supply shortages.

This immune circuit may protect the brain from Alzheimer's

A newly identified molecular pathway shifts microglia into a protective state, and may lead to Alzheimer's therapies that can reprogram the brain’s own immune defenses.

Room Reservation Calendar